Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Announcement of fully underwritten rights issue
Contributed by:
PR Newswire
Tags
Oncoinvent-AS
More Like This
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue
Inside information: Preliminary result of Bioretec Oy's rights issue
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue
Oncoinvent ASA announces oversubscribed private placement
The Board of Directors of SciBase resolves on a previously communicated rights issue of shares of approximately SEK 83 million
Final results of Bioretec Ltd's successful rights issue
Immunovia carries out a rights issue of units of approximately SEK 70 million and raises bridge loans
